BeStock  
Stocks › Cannabis & Hemp › TLRY

Tilray Brands TLRY

US equityMarket cap rank #3724WallStreetBetsCannabis & Hemp
$1.89 −$0.18 (-8.70%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $1.91 +1.29%
Open$2.03
Prev close$2.07
Day range$1.87 – $2.08
Volume7.89M
Market cap$279.32M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership10.9%-0.32 pts vs. prior quarter
Institutions holding251-5 vs. prior quarter
Insider trades (recent)34 buys / 16 sellsNet buying
Short interest13.22% of floatDays to cover 4.8 · as of 30 Oct 2026
Short-sale volume share19.0%5-day average of daily volume

Short-sale volume as % of daily volume

10%16%21%27%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$1.74M (10 inflow days, 10 outflow days).

Net flow by order size, last 20 sessions

−$1.7MSuper−$5,244Big−$2.4MMid−$2.7MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 4.9% of shares outstanding.

Largest holders

  • Tidal Investments LLC1.70%
  • UBS Asset Management0.99%
  • Irwin Simon0.89%
  • Susquehanna International Group, LLP0.70%
  • Morgan Stanley0.64%
  • Morgan Stanley Investment Management Inc.0.64%
  • Citadel Advisors LLC0.59%
  • Point72 Asset Management, L.P.0.44%

By investor type

  • Mutual Fund6.41%
  • Hedge Fund1.85%
  • Individual/Insider1.57%
  • Private Company1.20%
  • Public Company1.15%
  • Government Pension Fund0.18%
  • Sovereign Wealth Fund0.06%
  • Insurance Company0.04%

Reported short interest has fallen from 13.39% to 13.22% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
UBS Asset Management Mutual Fund 2026/Q3 +796,169 1.0%
Foundations Investment Advisors LLC Mutual Fund 2026/Q3 +65,927 0.0%
SLT Holdings, LLC Mutual Fund 2026/Q3 +65,750 0.0%
Connor, Clark & Lunn Investment Management Ltd. Mutual Fund 2026/Q3 +59,280 0.1%
Squarepoint OPS LLC Hedge Fund 2026/Q3 +46,553 0.1%
Quantbot Technologies, LP Hedge Fund 2026/Q3 +46,269 0.0%
Irwin Simon Individual/Insider 2026/Q3 +826,382 0.9%
Denise Faltischek Individual/Insider 2026/Q3 +142,569 0.2%
Mitchell Gendel Individual/Insider 2026/Q3 +130,396 0.1%
Carl Merton Individual/Insider 2026/Q3 +123,506 0.1%
Citadel Advisors LLC Hedge Fund 2026/Q3 +854,239 0.6%
Point72 Asset Management, L.P. Hedge Fund 2026/Q3 +648,506 0.4%
Susquehanna International Group, LLP Private Company 2026/Q3 +479,545 0.7%
Lazard Asset Management LLC Mutual Fund 2026/Q3 +394,715 0.3%
Morgan Stanley Public Company 2026/Q3 +365,150 0.7%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
25 Aug 2026 Irwin Simon Chairperson & CEO Derivative Exercise and Sale -642,450 $4.88 1,309,031
25 Aug 2026 Irwin Simon Chairperson & CEO Derivative Exercise and Retained +569,718 – 1,309,031
25 Aug 2026 Mitchell Gendel Global General Counsel & Corporate Secretary Derivative Exercise and Sale -84,962 $4.88 200,225
25 Aug 2026 Mitchell Gendel Global General Counsel & Corporate Secretary Derivative Exercise and Retained +75,342 – 200,225
25 Aug 2026 Carl Merton Chief Financial Officer Derivative Exercise and Sale -92,649 $4.88 215,556
25 Aug 2026 Carl Merton Chief Financial Officer Derivative Exercise and Retained +75,803 – 215,556
25 Aug 2026 Denise Faltischek Chief Strategy Officer and Head of M&A Derivative Exercise and Sale -94,459 $4.88 225,047
25 Aug 2026 Denise Faltischek Chief Strategy Officer and Head of M&A Derivative Exercise and Retained +83,762 – 225,047
5 Aug 2026 Mitchell Gendel Global General Counsel & Corporate Secretary Open Market Acquisition +2,500 $4.43 124,883
3 Aug 2026 Carl Merton Chief Financial Officer Open Market Acquisition +10,000 $4.62 139,753
2 Aug 2026 Denise Faltischek Chief Strategy Officer and Head of M&A Open Market Acquisition +2,500 $4.78 141,285
29 Jul 2026 David Hopkinson Independent Director Other Derivative Acquisition +62,657 – 62,657
29 Jul 2026 John Herhalt Independent Director Other Derivative Acquisition +62,657 – 62,657
29 Jul 2026 Thomas Looney Independent Director Other Derivative Acquisition +62,657 – 62,657
29 Jul 2026 Irwin Simon Chairperson & CEO Derivative Exercise and Sale -289,431 $4.20 739,313
29 Jul 2026 Irwin Simon Chairperson & CEO Derivative Exercise and Retained +256,664 – 739,313
29 Jul 2026 Mitchell Gendel Global General Counsel & Corporate Secretary Derivative Exercise and Sale -59,265 $4.20 122,383
29 Jul 2026 Mitchell Gendel Global General Counsel & Corporate Secretary Derivative Exercise and Retained +52,554 – 122,383
29 Jul 2026 Carl Merton Chief Financial Officer Derivative Exercise and Sale -39,370 $4.20 129,753
29 Jul 2026 Carl Merton Chief Financial Officer Derivative Exercise and Retained +37,703 – 129,753

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 19,539,742 13.2% 4.8
15 Oct 2026 21,522,431 14.6% 4.5
30 Sep 2026 18,790,909 12.7% 5.2
15 Sep 2026 19,418,606 14.1% 5.2
31 Aug 2026 18,060,770 13.1% 5.1
14 Aug 2026 18,427,714 13.4% 4.3

Discussion

No comments yet — be the first to weigh in on TLRY.

Sign in to join the discussion.

Scroll to Top